Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling.
The 14th EGFL-repeat (Ten14) of human tenascin cytotactin activates the epidermal growth factor receptor (EGFR) with micromolar affinity; however, unlike EGF, Ten14-mediated activation of EGFR does not lead to receptor internalization. As the divergent signaling pathways downstream of EGFR have been shown to be triggered from plasma membrane and cytosolic locales, we investigated whether Ten14-mediated surface restriction of EGFR resulted in altered biochemical and cellular responses as compared to EGF. Molecules associated with migratory cascades were activated to a relatively greater extent in response to Ten14, with very weak activation of proliferation-associated cascades. Activation of phospholipase C gamma (PLCgamma) and m-calpain, associated with lamellipod protrusion and tail retraction, respectively, were noted at even at sub-saturating doses of Ten14. However, activation of ERK/MAPK, p90RSK, and Elk1, factors affecting proliferation, remained low even at high Ten14 concentrations. Similar activation profiles were observed for EGF-treated cells at 4 degrees C, a maneuver that limits receptor internalization. We demonstrate a concurrent effect of such altered signaling on biophysical responses-sustained migration was observed at levels of Ten14 that activated PLCgamma, but did not stimulate proliferation significantly. Here, we present a novel class of EGFR ligands that can potentially signal as a part of the extracellular matrix, triggering specific intracellular signaling cascades leading to a directed cellular response from an otherwise pleiotropic receptor. This work extends the signaling paradigm of EGFL repeat being presented in a restricted fashion as part of the extracellular matrix.
Iyer
Anand Krishnan V
AK
Department of Pathology, University of Pittsburgh, Pittsburgh, Penssylvania 15261, USA.
Tran
Kien T
KT
Griffith
Linda
L
Wells
Alan
A
D000818:Animals; D002154:Calpain / Q000032:analysis; D002460:Cell Line; D002465:Cell Movement; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004815:Epidermal Growth Factor / Q000737:chemistry* / Q000302:isolation & purification / Q000378:metabolism* / Q000494:pharmacology; D066246:ErbB Receptors / Q000378:metabolism*; D004926:Escherichia coli / Q000235:genetics; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors; D005347:Fibroblasts / Q000378:metabolism*; D005419:Flavonoids / Q000494:pharmacology; D019085:Fluorescent Antibody Technique, Direct; D008024:Ligands; D008156:Luciferases / Q000032:analysis; D051379:Mice; D010957:Plasmids; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D012091:Repetitive Sequences, Nucleic Acid; D015398:Signal Transduction / Q000187:drug effects; D019063:Tenascin / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014162:Transfection; D014170:Transformation, Genetic
D005419:Flavonoids; D008024:Ligands; D011994:Recombinant Proteins; D019063:Tenascin; D004815:Epidermal Growth Factor; D008156:Luciferases; D066246:ErbB Receptors; D048049:Extracellular Signal-Regulated MAP Kinases; D002154:Calpain; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; D013936:Thymidine
Mol Cell Biol. 1999 Dec;19(12):8052-65
10567531
J Biol Chem. 2000 Jan 28;275(4):2390-8
10644690
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1489-94
10677489
Dev Dyn. 2000 Jun;218(2):235-59
10842355
Science. 1996 Dec 20;274(5295):2086-9
8953040
J Cell Biol. 1997 Oct 6;139(1):279-93
9314546
J Biol Chem. 1998 Jan 9;273(2):685-8
9422717
Gastroenterology. 1998 Mar;114(3):493-502
9496939
J Cell Biol. 1998 Mar 9;140(5):1255-63
9490736
Science. 1999 Jan 15;283(5400):381-7
9888852
EMBO J. 1999 Feb 1;18(3):664-74
9927426
J Biol Chem. 1999 Mar 26;274(13):8958-65
10085141
Med Biol Eng Comput. 1998 Jul;36(4):499-507
10198537
Int J Biochem Cell Biol. 1999 Jun;31(6):637-43
10404636
J Cell Biol. 1999 Sep 6;146(5):1107-16
10477763
Bioinformatics. 2005 May 1;21(9):2027-35
15657095
J Cell Sci. 2005 Jul 15;118(Pt 14):2997-3002
16014377
J Dermatol Sci. 2005 Oct;40(1):11-20
15993569
Biochem Biophys Res Commun. 2006 May 12;343(3):848-56
16564022
Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16
16829981
Curr Opin Cell Biol. 2006 Aug;18(4):351-7
16781855
J Cell Physiol. 2007 Jun;211(3):748-58
17311283
J Biol Chem. 2000 Sep 22;275(38):29894-9
10896662
Nat Cell Biol. 2001 Feb;3(2):165-72
11175749
J Cell Biol. 2001 Apr 30;153(3):599-612
11331309
Mol Biol Cell. 2001 Jun;12(6):1897-910
11408594
J Biol Chem. 2001 Jun 29;276(26):23341-8
11319218
EMBO J. 1995 Mar 1;14(5):951-62
7889942
J Cell Biol. 1996 Aug;134(3):689-98
8707848
Mol Biol Cell. 1996 Jun;7(6):871-81
8816994
Adv Cancer Res. 2000;78:31-101
10547668
Cell. 2001 Jul 13;106(1):1-4
11461694
J Cell Biol. 2001 Jul 23;154(2):459-68
11470832
Mol Cell Biol. 2002 Oct;22(20):7279-90
12242303
J Cell Biol. 2003 Apr 14;161(1):197-209
12695504
Trends Cell Biol. 2003 Jul;13(7):366-75
12837607
Curr Opin Cell Biol. 2003 Oct;15(5):547-56
14519389
Science. 2003 Dec 5;302(5651):1704-9
14657486
Wound Repair Regen. 2004 May-Jun;12(3):262-8
15225204
Cell. 1989 Oct 6;59(1):33-43
2790960
Science. 1990 Feb 23;247(4945):962-4
2305263
Science. 1990 Nov 30;250(4985):1253-6
1700866
Cell. 1991 May 3;65(3):435-41
1708307
J Cell Biol. 1994 Feb;124(4):547-55
8106552
J Cell Biol. 1994 Nov;127(3):847-57
7962064
J Biol Chem. 1999 Nov 26;274(48):34350-60
10567412